Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1987 1
1988 1
1989 1
2000 1
2002 1
2003 1
2006 1
2008 1
2009 1
2010 1
2012 1
2017 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Sánchez-Aguilera A, Montalbán C, de la Cueva P, Sánchez-Verde L, Morente MM, García-Cosío M, García-Laraña J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menárguez J, Sabín P, Mestre MJ, Méndez M, Fresno MF, Nicolás C, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group. Sánchez-Aguilera A, et al. Among authors: mestre mj. Blood. 2006 Jul 15;108(2):662-8. doi: 10.1182/blood-2005-12-5125. Epub 2006 Mar 21. Blood. 2006. PMID: 16551964 Free article.
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.
Mata E, Díaz-López A, Martín-Moreno AM, Sánchez-Beato M, Varela I, Mestre MJ, Santonja C, Burgos F, Menárguez J, Estévez M, Provencio M, Sánchez-Espiridión B, Díaz E, Montalbán C, Piris MA, García JF. Mata E, et al. Among authors: mestre mj. Oncotarget. 2017 Nov 30;8(67):111386-111395. doi: 10.18632/oncotarget.22799. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340061 Free PMC article.
Intrauterine candidiasis: report of four cases.
Meizoso T, Rivera T, Fernández-Aceñero MJ, Mestre MJ, Garrido M, Garaulet C. Meizoso T, et al. Among authors: mestre mj. Arch Gynecol Obstet. 2008 Aug;278(2):173-6. doi: 10.1007/s00404-007-0554-7. Epub 2008 Jan 24. Arch Gynecol Obstet. 2008. PMID: 18214512
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.
García JF, Camacho FI, Morente M, Fraga M, Montalbán C, Alvaro T, Bellas C, Castaño A, Díez A, Flores T, Martin C, Martinez MA, Mazorra F, Menárguez J, Mestre MJ, Mollejo M, Sáez AI, Sánchez L, Piris MA; Spanish Hodgkin Lymphoma Study Group. García JF, et al. Among authors: mestre mj. Blood. 2003 Jan 15;101(2):681-9. doi: 10.1182/blood-2002-04-1128. Epub 2002 Sep 12. Blood. 2003. PMID: 12393683 Free article.
Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place.
Herreros B, Rodríguez-Pinilla SM, Pajares R, Martínez-Gónzalez MA, Ramos R, Munoz I, Montes-Moreno S, Lozano M, Sánchez-Verde L, Roncador G, Sánchez-Beato M, de Otazu RD, Pérez-Guillermo M, Mestre MJ, Bellas C, Piris MA. Herreros B, et al. Among authors: mestre mj. Leukemia. 2010 Apr;24(4):872-6. doi: 10.1038/leu.2009.285. Epub 2010 Jan 14. Leukemia. 2010. PMID: 20072150 No abstract available.
p53 expression in two cases of spiradenocarcinomas.
Fernández-Aceñero MJ, Manzarbeitia F, Mestre MJ, Requena L. Fernández-Aceñero MJ, et al. Among authors: mestre mj. Am J Dermatopathol. 2000 Apr;22(2):104-7. doi: 10.1097/00000372-200004000-00003. Am J Dermatopathol. 2000. PMID: 10770428
A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.
Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, Poderos C, Bellas C, Fresno MF, Morante C, Mestre MJ, Mendez M, Mazorra F, Conde E, Castaño A, Sánchez-Godoy P, Tomas JF, Morente MM, Piris MA, García JF; Spanish Hodgkin's Lymphoma Study Group. Sánchez-Espiridión B, et al. Among authors: mestre mj. Clin Cancer Res. 2009 Feb 15;15(4):1367-75. doi: 10.1158/1078-0432.CCR-08-1119. Clin Cancer Res. 2009. PMID: 19228737
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group. Guisado-Vasco P, et al. Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22185637
13 results